Biological Potential and Bioaccessibility of Encapsulated Curcumin into Cetyltrimethylammonium Bromide Modified Cellulose Nanocrystals.

Curcumin is a natural phenolic compound with important biological functions. Despite its demonstrated efficacy in vitro, curcumin biological activities in vivo are dependent on its bioaccessibility and bioavailability, which have been highlighted as a crucial challenge. Cetyltrimethylammonium bromide-modified cellulose nanocrystals (CNC-CTAB) have been shown to be effective in curcumin encapsulation, as they have the potential to enhance biological outcomes. This study evaluated the biological effects of curcumin encapsulated within CNC-CTAB structures, namely its antioxidant, anti-inflammatory and antimicrobial properties, as well as the release profile under digestion conditions and intestinal permeability. Encapsulated curcumin demonstrated antioxidant and anti-inflammatory properties, effectively reducing reactive oxygen species and cytokine production by intestinal cells. The delivery system exhibited antimicrobial properties against Campylobacter jejuni bacteria, further suggesting its potential in mitigating intestinal inflammation. The system showed the ability to protect curcumin from degradation and facilitate its interaction with the intestinal epithelium, highlighting the potential of CNC-CTAB as carrier to enhance curcumin intestinal biological functions.

Carboxymethyl Cellulose as a Food Emulsifier: Are Its Days Numbered?

Carboxymethyl cellulose use in industry is ubiquitous. Though it is recognized as safe by the EFSA and FDA, newer works have raised concerns related to its safety, as in vivo studies showed evidence of gut dysbiosis associated with CMC's presence. Herein lies the question, is CMC a gut pro-inflammatory compound? As no work addressed this question, we sought to understand whether CMC was pro-inflammatory through the immunomodulation of GI tract epithelial cells. The results showed that while CMC was not cytotoxic up to 25 mg/mL towards Caco-2, HT29-MTX and Hep G2 cells, it had an overall pro-inflammatory behavior. In a Caco-2 monolayer, CMC by itself increased IL-6, IL-8 and TNF-α secretion, with the latter increasing by 1924%, and with these increases being 9.7 times superior to the one obtained for the IL-1ß pro-inflammation control. In co-culture models, an increase in secretion in the apical side, particularly for IL-6 (692% increase), was observed, and when RAW 264.7 was added, data showed a more complex scenario as stimulation of pro-inflammatory (IL-6, MCP-1 and TNF-α) and anti-inflammatory (IL-10 and IFN-ß) cytokines in the basal side was observed. Considering these results, CMC may exert a pro-inflammatory effect in the intestinal lumen, and despite more studies being required, the incorporation of CMC in foodstuffs must be carefully considered in the future to minimize potential GI tract dysbiosis.

Design of Innovative Biocompatible Cellulose Nanostructures for the Delivery and Sustained Release of Curcumin.

Poor aqueous solubility, stability and bioavailability of interesting bioactive compounds is a challenge in the development of bioactive formulations. Cellulose nanostructures are promising and sustainable carriers with unique features that may be used in enabling delivery strategies. In this work, cellulose nanocrystals (CNC) and cellulose nanofibers were investigated as carriers for the delivery of curcumin, a model liposoluble compound. Nanocellulose modification with the surfactant cetyltrimethylammonium bromide (CTAB), tannic acid and decylamine (TADA), and by TEMPO-mediated oxidation were also tested and compared. The carrier materials were characterized in terms of structural properties and surface charge, while the delivery systems were evaluated for their encapsulation and release properties. The release profile was assessed in conditions that mimic the gastric and intestinal fluids, and cytotoxicity studies were performed in intestinal cells to confirm safe application. Modification with CTAB and TADA resulted in high curcumin encapsulation efficiencies of 90 and 99%, respectively. While no curcumin was released from TADA-modified nanocellulose in simulated gastrointestinal conditions, CNC-CTAB allowed for a curcumin-sustained release of ca. 50% over 8 h. Furthermore, the CNC-CTAB delivery system showed no cytotoxic effects on Caco-2 intestinal cells up to 0.125 g/L, meaning that up to this concentration the system is safe to use. Overall, the use of the delivery systems allowed for the reduction in the cytotoxicity associated with higher curcumin concentrations, highlighting the potential of nanocellulose encapsulation systems.

Comparative Study of Green and Traditional Routes for Cellulose Extraction from a Sugarcane By-Product.

Sugarcane bagasse (SCB) is the main residue of the sugarcane industry and a promising renewable and sustainable lignocellulosic material. The cellulose component of SCB, present at 40-50%, can be used to produce value-added products for various applications. Herein, we present a comprehensive and comparative study of green and traditional approaches for cellulose extraction from the by-product SCB. Green methods of extraction (deep eutectic solvents, organosolv, and hydrothermal processing) were compared to traditional methods (acid and alkaline hydrolyses). The impact of the treatments was evaluated by considering the extract yield, chemical profile, and structural properties. In addition, an evaluation of the sustainability aspects of the most promising cellulose extraction methods was performed. Among the proposed methods, autohydrolysis was the most promising approach in cellulose extraction, yielding 63.5% of a solid fraction with ca. 70% cellulose. The solid fraction showed a crystallinity index of 60.4% and typical cellulose functional groups. This approach was demonstrated to be environmentally friendly, as indicated by the green metrics assessed (E(nvironmental)-factor = 0.30 and Process Mass Intensity (PMI) = 20.5). Autohydrolysis was shown to be the most cost-effective and sustainable approach for the extraction of a cellulose-rich extract from SCB, which is extremely relevant for aiming the valorization of the most abundant by-product of the sugarcane industry.

Spent Yeast Waste Streams as a Sustainable Source of Bioactive Peptides for Skin Applications.

Spent yeast waste streams are a byproduct obtained from fermentation process and have been shown to be a rich secondary source of bioactive compounds such as phenolic compounds and peptides. The latter are of particular interest for skin care and cosmetics as they have been shown to be safe and hypoallergenic while simultaneously being able to exert various effects upon the epidermis modulating immune response and targeting skin metabolites, such as collagen production. As the potential of spent yeast's peptides has been mainly explored for food-related applications, this work sought to understand if peptide fractions previously extracted from fermentation engineered spent yeast (Saccharomyces cerevisiae) waste streams possess biological potential for skin-related applications. To that end, cytotoxic effects on HaCat and HDFa cells and whether they were capable of exerting a positive effect upon the production of skin metabolites relevant for skin health, such as collagen, hyaluronic acid, fibronectin and elastin, were evaluated. The results showed that the peptide fractions assayed were not cytotoxic up to the highest concentration tested (500 µg/mL) for both cell lines tested. Furthermore, all peptide fractions showed a capacity to modulate the various target metabolites production with an overall positive effect being observed for the four fractions over the six selected targets (pro-collagen IαI, hyaluronic acid, fibronectin, cytokeratin-14, elastin, and aquaporin-9). Concerning the evaluated fractions, the overall best performance (Gpep > 1 kDa) was of an average promotion of 41.25% over the six metabolites and two cell lines assessed at a concentration of 100 µg/mL. These results showed that the peptide fractions assayed in this work have potential for future applications in skin-related products at relatively low concentrations, thus providing an alternative solution for one of the fermentation industry's waste streams and creating a novel and highly valuable bioactive ingredient with encompassing activity to be applied in future skin care formulations.

Novel Micro- and Nanocellulose-Based Delivery Systems for Liposoluble Compounds.

Poor aqueous solubility of bioactive compounds is becoming a pronounced challenge in the development of bioactive formulations. Numerous liposoluble compounds have very interesting biological activities, but their low water solubility, stability, and bioavailability restrict their applications. To overcome these limitations there is a need to use enabling delivering strategies, which often demand new carrier materials. Cellulose and its micro- and nanostructures are promising carriers with unique features. In this context, this review describes the fast-growing field of micro- and nanocellulose based delivery systems with a focus on the release of liposoluble bioactive compounds. The state of research on this field is reviewed in this article, which also covers the chemistry, preparation, properties, and applications of micro- and nanocellulose based delivery systems. Although there are promising perspectives for introducing these materials into various fields, aspects of safety and toxicity must be revealed and are discussed in this review. The impact of gastrointestinal conditions on the systems and on the bioavailability of the bioactive compounds are also addressed in this review. This article helps to unveil the whole panorama of micro- and nanocellulose as delivery systems for liposoluble compounds, showing that these represent a great promise in a wide range of applications.

Encapsulation of cosmetic active ingredients for topical application--a review.

Microencapsulation is finding increasing applications in cosmetics and personal care markets. This article provides an overall discussion on encapsulation of cosmetically active ingredients and encapsulation techniques for cosmetic and personal care products for topical applications. Some of the challenges are identified and critical aspects and future perspectives are addressed. Many cosmetics and personal care products contain biologically active substances that require encapsulation for increased stability of the active materials. The topical and transdermal delivery of active cosmetic ingredients requires effective, controlled and safe means of reaching the target site within the skin. Preservation of the active ingredients is also essential during formulation, storage and application of the final cosmetic product. Microencapsulation offers an ideal and unique carrier system for cosmetic active ingredients, as it has the potential to respond to all these requirements. The encapsulated agent can be released by several mechanisms, such as mechanical action, heat, diffusion, pH, biodegradation and dissolution. The selection of the encapsulation technique and shell material depends on the final application of the product, considering physical and chemical stability, concentration, required particle size, release mechanism and manufacturing costs.

Punto de corte del grosor endometrial ecográfico en la determinación de patología endometrial en mujeres con metrorragia posmenopáusica / Accurate threshold of endometrial thickness in determination of endometrial pathology in women with postmenopausal vaginal bleeding

Objetivo: Revisar la literatura médica para establecer un punto de corte del grosor endometrial mediante ecografía transvaginal que permita discriminar la presencia o ausencia de patología endometrial en el grupo de pacientes que consulta por metrorragia posmenopáusica. Metodología: La búsqueda en MEDLINE de artículos publicados entre los años 1988 y marzo de 2000, dio como resultado 33 publicaciones atigentes al tema de revisión. De los artículos incluidos en la revisión que cumplían con los criterios de selección, se presentan y comentan dos de ellos: Un estudio multicéntrico publicado el año 1995 y un metaanálisis publicado el año 1998 (12, 13). Análisis: En el primer estudio de B. Karlsson, S. Granberg y cols. (13) el objetivo fue encontrar, mediante la ecografía transvaginal, el grosor endometrial bajo el cual el riesgo de presentar anormalidades endometriales en mujeres con metrorragia postmenopáusica es bajo. La ecografía transvaginal fue realizada previamente al raspado diagnóstico que constituyó el estándar ideal. Se concluyó que la sensibilidad para pesquisar patología endometrial es semejante en los puntos de corte 4 y 5 mm, pero se destaca que con 4 mm se diagnóstico el 100 por ciento de los casos de cáncer de endometrio, mientras que con 5 mm se perdieron 2 casos (1,8 por ciento). En el metaanálisis de Smith-Bindman se incluyeron 35 estudios para evaluar la capacidad diagnóstica de la ecografía transvaginal en relación con patología endometrial, en 5892 pacientes con metrorragia postmenopáusica, estratificadas según uso o no de terapia hormonal de reemplazo. La prevalencia de patologías endometriales fue de un 40 por ciento y del cáncer fue de un 13 por ciento. Los autores concluyen que utilizando un grosor de 5 mm, la sensibilidad de la ecografía transvaginal es de un 92 por ciento para la detección de patología endometrial, y de un 96 por ciento para la detección de cáncer endometrial en particular, cifras que no cambian con el uso de terapia hormonal de reemplazo. Conclusión: La visualización de un grosor endometrial menor o igual a 5 mm permite destacar con bastante certeza la presencia de patología endometrial y orienta los casos en que debe efectuarse un estudio endometrial